How many clinical trials are tracked of dihydroergotamine?

4 trials are tracked, 1 with published results.

Mode

All Oncology Infectious Disease Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Anesthesiology & Pain Medicine Genetics & Precision Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Urology Emergency Medicine Ophthalmology Dermatology Hematology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

dihydroergotamine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of dihydroergotamine

4 trials tracked of dihydroergotamine: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 6 citations.

4Trials tracked

3Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 3 3 Other / NA 1

Phase 3 A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine Completed · 6 cited
Phase 3 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine Completed
Phase 3 A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine Completed
N/A A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.